Biosimilars in the Treatment of Inflammatory Bowel Disease: Supporting Evidence in 2017.
Scott FI, Lichtenstein GR. Biosimilars in the Treatment of Inflammatory Bowel Disease: Supporting Evidence in 2017. Curr Treat Options Gastroenterol. 2018 Mar; 16(1):147-164.